Search filters

List of works by Ingrid Struman

A peptide mimicking the C‐terminal part of the reactive center loop induces the transition to the latent form of plasminogen activator inhibitor type‐1

scientific article published on February 17, 2012

Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance

scientific article published on 10 June 2004

Corrigendum: PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin

scientific article published on 01 May 2015

Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer

scientific article published in April 2015

Exploring the RNA landscape of endothelial exosomes

scientific article

Inhibition of tumor growth and metastasis establishment by adenovirus-mediated gene transfer delivery of the antiangiogenic factor 16K hPRL.

scientific article published on 28 August 2007

Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p

scientific article published on 05 August 2020

MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells

scientific article published on 26 June 2013

MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy

scientific article published on 24 April 2013

NF-kappaB activation in endothelial cells is critical for the activity of angiostatic agents

scientific article published on 25 August 2009

PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin.

scientific article

Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy

scientific article published on June 28, 2013

Prolactin/growth hormone-derived antiangiogenic peptides highlight a potential role of tilted peptides in angiogenesis.

scholarly article

Sprouty1, a new target of the angiostatic agent 16K prolactin, negatively regulates angiogenesis

scientific article

The angiostatic 16K human prolactin overcomes endothelial cell anergy and promotes leukocyte infiltration via nuclear factor-kappaB activation

scientific article published on 3 April 2007

The antiangiogenic 16K prolactin impairs functional tumor neovascularization by inhibiting vessel maturation

scientific article

The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-kappaB

scientific article published on 05 June 2003

The antiangiogenic factor, 16-kDa human prolactin, induces endothelial cell cycle arrest by acting at both the G0-G1 and the G2-M phases

scientific article published on 03 March 2005

miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization.

scientific article published on 6 February 2014